Figure 5: Challenges hindering the use of machine learning in drug development

Figure 5: Challenges hindering the use of machine learning in drug development
Uploaded by U.S. Government Accountability Office
License United States Government Work
Comments 0
Favorites 0
Views 10,625
Date uploaded 2020-02-03
Tags gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao20215sp, artificialintelligenceinhealthcare, ai, artificialintelligence, fda, foodanddrugadministration, hipaa, healthinsuranceportabilityandaccountabilityactof1996, ind, investigationalnewdrugapplication, melloddy, machinelearningledgerorchestrationfordrugdiscovery, mlpds, machinelearningforpharmaceuticaldiscoveryandsynthesisconsortium, nda, newdrugapplication, ncats, nationalcenterforadvancingtranslationalsciences, nih, nationalinstitutesofhealth, rd, researchanddevelopment, nationalacademyofmedicine, nam, technologyassessment
Visibility public